Latest news for Kissei Pharmaceutical (OTC:KSPHF) Stock

Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

KISSEI PHARM CO LTD by Kissei Pharmaceutical Co., Ltd.

Kissei Pharmaceutical Co Ltd

Kissei Pharmaceutical Co (JP:4547) has released an update. Kissei Pharmaceutical Co. has secured exclusive rights to develop and commercialize the ...

Kissei Pharmaceutical Expands AML Treatment Options

Kissei Pharmaceutical Co (JP:4547) has released an update. Kissei Pharmaceutical Co. has entered into a research collaboration with Reborna Bioscie...

Kissei Partners with Reborna for Rare Disease Therapies

Kissei Pharmaceutical Co (JP:4547) has released an update. Kissei Pharmaceutical Co. has announced the first commercial sale in Germany of YSELTY, ...

Kissei Pharmaceutical Launches YSELTY in Europe

Kissei Pharmaceutical Co (JP:4547) has released an update. Kissei Pharmaceutical Co., Ltd. has announced its decision to acquire up to 1,400,000 of...

Kissei Pharmaceutical Plans Share Buyback and Cancellation

Kissei Pharmaceutical Co (JP:4547) has released an update. Kissei Pharmaceutical has completed a repurchase of 1.4 million of its own shares, costi...

Kissei Pharmaceutical Finalizes Share Buyback and Cancellation

Kissei Pharmaceutical Co (JP:4547) has released an update. Kissei Pharmaceutical Co reported a 14.8% increase in net sales for the second quarter o...

Comments

Kissei Pharmaceutical

News

Latest news for Kissei Pharmaceutical (OTC:KSPHF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga